Praxis Precision Medicines, Inc. PRAX Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from Praxis Precision Medicines, Inc.’s reported figures.
Based on the most recent quarter.
The official record: Praxis Precision Medicines, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Praxis Precision Medicines, Inc.'s current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Praxis Precision Medicines, Inc.'s current ratio?
- Praxis Precision Medicines, Inc. (PRAX) reported current ratio of 15.9× in Q1 2026.
- How has Praxis Precision Medicines, Inc.'s current ratio changed year-over-year?
- Praxis Precision Medicines, Inc.'s current ratio increased by 88.1% year-over-year, from 8.4× to 15.9×.
- What is the long-term trend for Praxis Precision Medicines, Inc.'s current ratio?
- Over 5 years (2020 to 2025), Praxis Precision Medicines, Inc.'s current ratio has grown at a -11.9% compound annual growth rate (CAGR), from 19.2× to 10.2×.
- What does current ratio mean?
- Whether the company has enough short-term assets to cover its short-term bills.
- How do you interpret current ratio?
- Above 1.0 means short-term assets cover short-term liabilities. Very high values can signal idle cash or bloated inventory/receivables rather than strength — there's a healthy middle, not 'more is better'.
- How does current ratio compare across companies?
- Comparable within an industry. Working-capital-light businesses can operate safely below 1.0 by collecting before they pay.